|
B5.Updated with additional information received.The device has been returned to the manufacturer but analysis remains pending.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Product analysis: no damage was found with the marksman catheter hub, body, or distal tip.An attempt was made to flush the marksman catheter but was found occluded with blood.The marksman catheter was dissected (cut), and the pipeline flex braid was removed from within the catheter's proximal end.The braid ends were found damaged (frayed).The proximal braid end was found open; however, the distal end was not fully open.An in-house mandrel was inserted into the marksman catheter but was unable to pass through the catheter hub.Upon microscopic inspection, the pipeline flex ptfe sleeves and tip coil were found stuck within the catheter hub and could not be removed.It appears the pipeline flex pusher distal core wire separated at the ptfe sleeves.The remaining pipeline flex pusher was not returned.As the pipeline flex pusher was not returned and the ptfe sleeves could not be removed from within the marksman catheter hub, sem analysis could not be performed.Conclusion: based on the device analysis and reported information, the customer¿s ¿failure/incomplete open distal¿ report was confirmed.It is possible the damage found with the pipeline flex braid, the patient¿s ¿moderate¿ vessel tortuosity, and the placement of the braid within a bend contributed to the event.Regarding the pusher separation, this event is similar to events that had already been investigated, and another investigation is not necessary.Based on the formal investigation, separation can occur due to certain use conditions such as excessive force or patient vessel tortuosity.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|